New Cholesterol Formula Containing FDA-Approved Ingredient To Help Lower Heart Disease Risk

Main Category: Heart Disease
Also Included In: Cholesterol
Article Date: 25 Jul 2005 - 0:00 PST

email to a friend   printer friendly   opinions  

Gero Vita International (GVI) announced the launch of Cholester-Watch(TM), a cholesterol support formula with phytosterols, or plant sterols, as the main ingredient to help reduce the risk of heart disease. The new product is currently on the market.

The FDA has approved the following claim for phytosterols: "Foods containing at least 0.4 gram per serving of plant sterols, eaten twice a day with meals for a daily total intake of at least 0.8 gram, as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease."*

To date, more than 20 clinical studies on the effects of phytosterols on cholesterol have been conducted. One study published in Food Technology indicated that consuming two grams of phytosterols daily could slash the risk of heart disease by 25% (Hicks 2001). Another study published in the American Journal of Clinical Nutrition revealed that phytosterols interfered with cholesterol absorption by 33% to 42% (Mattson 1982).

"With heart disease as the number-one killer of both men and women in this country, it is critical that consumers become aware of their options when it comes to strengthening their cardiovascular health. Knowledge is power. Therefore, educating Americans about sound nutritional research as well as providing supplements based on legitimate science are two very effective ways to help them achieve healthy longevity," said Dr. Mohammad Khalid, executive vice president.

Founded in 1989, Gero Vita International is an innovative nutraceutical company that has been a pioneer in the natural health care industry.

GVI has developed and marketed more than 100 unique products to support and maintain bone and joint health, vision, brain health, cardiovascular function, blood pressure, bladder control, sleep, mood, energy and vitality, venous function, weight management, prostate health, menopausal health, sexual responsiveness, immune health, colon care, respiratory health, and beauty and skin care. GVI also publishes the Journal of Longevity, a monthly magalog designed to provide baby boomers and seniors with science-based information regarding GVI formulas and health issues.

With a Medical Advisory Board consisting of more than 50 doctors, GVI is a privately held company headquartered in Los Angeles, California (http://www.gvi.com).

*This claim has not been finalized by the FDA and serves as its interim stance. A final ruling will soon be issued.

• Additional
• References
• Citations